AVERY CROSS: Open Payments
NPI 1487389706 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,290 in 57 payments from 17 companies in 2025. Trend: 2023 $92 · 2024 $213 · 2025 $1,290
Food & beverage: $1,290
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $406 |
| Axsome Therapeutics, Inc. | 8 | $251 |
| AstraZeneca Pharmaceuticals LP | 6 | $99 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $89 |
| Dexcom, Inc. | 4 | $78 |
| Exact Sciences Corporation | 3 | $59 |
| Kowa Pharmaceuticals America, Inc. | 3 | $48 |
| GlaxoSmithKline, LLC. | 2 | $46 |
| ABBVIE INC. | 2 | $37 |
| Lundbeck LLC | 2 | $30 |
Products named: Rybelsus, Auvelity, Ozempic, Symbravo, Wegovy, Kerendia, FARXIGA, Dexcom G6 Transmitter.
Industry payments across TX — which companies pay providers there.
